Very Low Dose Oral Anticoagulation and Thromboembolic and Bleeding Complications
Terminated
Klinikum Ludwigshafen
Phase 4
2006-01-01
We aim to investiagte whether very low dose self management of oral anticoagulation is
superior to low dose oral anticoagulation in order to prevent bleeding events in patients
undergoing mechanuical heart valve replacement.
Very Low Dose Oral Anticoagulation and Thromboembolic and Bleeding Complications
Terminated
University of Kiel
Phase 4
2006-01-01
We aim to investiagte whether very low dose self management of oral anticoagulation is
superior to low dose oral anticoagulation in order to prevent bleeding events in patients
undergoing mechanuical heart valve replacement.
Very Low Dose Oral Anticoagulation and Thromboembolic and Bleeding Complications
Terminated
Heart and Diabetes Center North-Rhine Westfalia
Phase 4
2006-01-01
We aim to investiagte whether very low dose self management of oral anticoagulation is
superior to low dose oral anticoagulation in order to prevent bleeding events in patients
undergoing mechanuical heart valve replacement.
Study to Find Out the Appropriate Initial Dose of the Anticoagulant Drug Phenprocoumon
Completed
Cantonal Hospital of St. Gallen
Phase 4
2007-01-01
Oral anticoagulation is often initiated in hospitalized patients. Although the therapeutic
range of phenprocoumon is narrow, the individual drug demands unfortunately vary greatly
between persons. Our group recently developed two dosing algorithms for the initiation of
anticoagulation based on clinical predictors such as age, gender, body weight and laboratory
values.
The aim of the proposed study is to prospectively evaluate the efficacy and safety of these
two algorithms in medical and orthopedic inpatients, as well as in a group of outpatients and
possibly in a geriatric collective.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.